Europe Insulin Pens Market Size- By Product Type- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Europe Insulin Pens Market Introduction and Overview

According to SPER market research, 'Europe Insulin Pens Market Size- By Product Type - Regional Outlook, Competitive Strategies and Segment Forecast to 2033'state that the Europe Insulin Pens Market is predicted to reach USD 2.29 Billion by 2033 with a CAGR of 2.1%.

Insulin pens are devices that allow diabetics to deliver insulin in a simple and efficient manner. They are made up of an insulin cartridge, a disposable needle, and a pen-like device that allows users to dial in their desired dosage. Insulin pens exist in two varieties: reusable pens, which may be refilled with insulin cartridges, and disposable pens, which are pre-filled and discarded after use.

The COVID-19 pandemic has had a substantial impact on the European Insulin Pens Market, notably on Type 1 diabetes patients who are more susceptible to severe consequences. Manufacturers, in partnership with local governments, ensured that diabetic patients received insulin devices throughout the pandemic. Medical professionals encourage greater blood glucose monitoring to successfully manage diabetes, which has resulted in an increase in the use of insulin pens.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Product Type

Regions covered France, Germany, Italy, Russia, Spain, United Kingdom, Rest of Europe

Companies Covered Biocon, Eli Lilly, Medtronic, Novo Nordisk, Sanofi, Wockhardt, Others

Europe Insulin Pens Market Segmentation:

By Product Type: Based on the Product Type, Europe Insulin Pens Market is segmented as; Cartridges in Reusable Pens, Disposable Insulin Pens.

By Region: This research also includes data for France, Germany, Italy, Russia, Spain, United Kingdom, Rest of Europe.

Product Code: HLCA2431

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Europe Insulin Pens Market

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Europe Insulin Pens Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Insulin Pens Market

7. Europe Insulin Pens Market, By Product Type (USD Million)

7.1. Europe Insulin Pens Market Value Share and Forecast, By Product Type, 2024-2033
7.2. Cartridges in Reusable Pens
7.3. Disposable Insulin Pens

8. Europe Insulin Pens Market Forecast, 2020-2033 (USD Million)

8.1. Europe Insulin Pens Market Size and Market Share

9. Europe Insulin Pens Market, By Product Type, 2020-2033 (USD Million)

9.1. Europe Insulin Pens Market Size and Market Share By Product Type (2020-2026)
9.2. Europe Insulin Pens Market Size and Market Share By Product Type (2027-2033)

10. Europe Insulin Pens Market, By Region, 2020-2033 (USD Million)

10.1. Europe Insulin Pens Market Size and Market Share By Region (2020-2026)
10.2. Europe Insulin Pens Market Size and Market Share By Region (2027-2033)
10.3. France
10.4. Germany
10.5. Italy
10.6. Russia
10.7. Spain
10.8. United Kingdom
10.9. Rest of Europe

11. Company Profile

11.1. Biocon
- 11.1.1. Company details
- 11.1.2. Financial outlook
- 11.1.3. Product summary
- 11.1.4. Recent developments
11.2. Eli Lilly
- 11.2.1. Company details
- 11.2.2. Financial outlook
- 11.2.3. Product summary
- 11.2.4. Recent developments
11.3. Medtronic
- 11.3.1. Company details
- 11.3.2. Financial outlook
- 11.3.3. Product summary
- 11.3.4. Recent developments
11.4. Novo Nordisk
- 11.4.1. Company details
- 11.4.2. Financial outlook
- 11.4.3. Product summary
- 11.4.4. Recent developments
11.5. Sanofi
- 11.5.1. Company details
- 11.5.2. Financial outlook
- 11.5.3. Product summary
- 11.5.4. Recent developments
11.6. Wockhardt
- 11.6.1. Company details
- 11.6.2. Financial outlook
- 11.6.3. Product summary
- 11.6.4. Recent developments
11.7. Others